2 completed, 1 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
Follow Pancoast Syndrome: new trials by email Literature Review of Pancoast Syndrome trials Research Report on Pancoast Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors Carboplatin, Paclitaxel, Nivolumab - NSCLC, Pancoast Tumor | Phase 2 | Active not recruiting | Fundación GECP | 22 | 2023-05-12 | 2026-05-05 |
| Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806) mitomycin C, vindesine, cisplatin and radiotherapy - Pulmonary Neoplasm | Phase 2 | Completed | Japan Clinical Oncology Group | 75 | 1999-05-01 | 2016-09-22 |
| Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors Surgery, Chest Irradiation, Cisplatin - Lung Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 38 | 1993-10-01 | 2016-06-30 |
Lung Neoplasms (2)
Lung Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Lung Neoplasms (1)
Cisplatin (2) · Radiotherapy (2) · Carboplatin (1) · Etoposide (1) · Mitomycin (1) · Nivolumab (1) · Paclitaxel (1) · Surgical Procedures, Operative (1) · Vindesine (1)
Fundación GECP (1) · Japan Clinical Oncology Group (1) · M.D. Anderson Cancer Center (1)
Japan (1) · Spain (1) · United States (1)
Harubumi Kato, M.D., Ph.D. (1) · Mariano Provencio, MD (1) · Ritsuko Komaki, MD (1)